Fempro 2.5 Mg
Fempro 2.5 Mg for the treatment of breast cancer in post-menopausal women. Sometimes, excess estrogen in the body can stimulate cancerous cells to grow in the breasts. Letrozole is commonly used to treat estrogen-dependent tumours. It belongs to a group of drugs called aromatase inhibitors that prevents the conversion of androgen to estrogen in women. In menopausal women, the ovaries do not produce estrogen. Instead, the body fat, using a protein called aromatase, produce it. Letrozole inhibits the production of estrogen and thus prevents the growth of a tumour.
Drug = Letrozole
Strength = 2.5 Mg
Manufacturer = Cipla Ltd.
How To Take
Take Fempro 2.5 Mg in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Fempro 2.5 Mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Fempro 2.5 Mg
Anxiety and nervousness
Immediately proceed to your nearest emergency department if you suffer an allergic reaction. Symptoms usually associated with such a reaction include difficulty breathing or swallowing, chest tightness, swelling, skin rashes, and hives.
Fempro 2.5 Mg is not always suitable for all patients. Always consult your health care provider prior to using this medication if you are pregnant, breastfeeding, trying to conceive, using any other medication (prescription or non-prescription), using any herbal products or supplements, or if you have an
The correct dosage and prescription commonly depend on the patient and the condition being treated. Do not adjust your dosage without the approval of your health care provider. This product is only for use as prescribed and instructed.
Fempro 2.5 Mg are used to treat breast cancer in postmenopausal women and are used as first line therapy for breast cancer that has been detected in an advanced or metastatic (spread outside the breast tissue) state. Fempro 2.5 Mg are also used as additional or adjuvant treatment for early breast cancer in conjunction with other breast cancer treatment with tamoxifen, or if tamoxifen therapy has not helped prevent progression of the tumour.